Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's
Status:
Withdrawn
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and feasibility of using allogeneic bone
marrow derived mesenchymal stem cells (MSCs) to treat people with an ileal pouch anal
anastomosis (IPAA) who develop a fistula in the setting of Crohn's disease of the pouch.